What is the next step for a patient with a Nexplanon (etonogestrel implant) experiencing heavy menstrual bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Heavy Menstrual Bleeding with Nexplanon

For a patient with Nexplanon experiencing heavy menstrual bleeding, first rule out pregnancy and underlying pathology, then initiate a trial of mefenamic acid 500 mg three times daily for 5 days or celecoxib 200 mg daily for 5 days; if bleeding persists despite treatment and remains unacceptable to the patient, remove the implant and transition to a levonorgestrel-releasing IUD. 1

Initial Assessment Steps

Rule out pregnancy immediately in all reproductive-age women with abnormal bleeding, as this could indicate pregnancy including ectopic pregnancy. 1, 2

Assess hemodynamic stability by checking for tachycardia or hypotension—bleeding that saturates a large pad or tampon hourly for at least 4 hours warrants urgent evaluation. 1, 2

Screen for underlying gynecological conditions:

  • Test for sexually transmitted infections, particularly in adolescents 1
  • Consider medication interactions, especially if the patient is on anticoagulants (factor Xa inhibitors cause 32% incidence of abnormal uterine bleeding) 1, 2
  • Evaluate for new pathologic uterine conditions such as polyps or fibroids 3
  • Consider rare implant fracture, though this is uncommon 1

Understanding Nexplanon Bleeding Patterns

Prolonged bleeding affects approximately 18% of Nexplanon users and is the most common reason for discontinuation. 1 Unlike other continuous contraceptive methods, bleeding patterns with Nexplanon may not improve over time—this is a critical counseling point. 1

Pharmacologic Treatment Algorithm

If no underlying pathology is identified and the patient desires treatment:

First-line NSAIDs:

  • Mefenamic acid 500 mg three times daily for 5 days (demonstrated significant cessation of bleeding within 7 days) 1
  • Celecoxib 200 mg daily for 5 days (also demonstrated efficacy) 1

Second-line hormonal options (if medically eligible):

  • Low-dose combined oral contraceptives for 10-20 days 3, 1
  • Estrogen therapy for 10-20 days 3, 1

When to Remove the Implant

Remove Nexplanon if:

  • Bleeding remains unacceptable despite treatment attempts 1
  • Patient experiences hemodynamic instability 1
  • Underlying pathology is identified that contraindicates continued use 1
  • Patient preference dictates removal after informed discussion of alternatives 1

Alternative Contraceptive Strategy

Transition to a levonorgestrel-releasing IUD (20 μg/day) as the preferred alternative long-acting reversible contraceptive. This device reduces menstrual blood loss by 71-95% and is the most effective medical approach for heavy menstrual bleeding, comparable to endometrial ablation. 3, 1, 2 The main effect is at the endometrial level with minimal systemic progesterone absorption. 3

Critical Counseling Points

Enhanced counseling before insertion about expected bleeding patterns has been shown to reduce discontinuation rates in clinical trials. 1 Reassurance that bleeding irregularities are generally not harmful is essential, though this reassurance must be balanced against the reality that Nexplanon bleeding patterns may not improve over time. 1

Common pitfall to avoid: Do not assume bleeding will improve with time as it does with other progestin-only methods—Nexplanon is unique in that bleeding patterns often persist. 1

References

Guideline

Management of Prolonged Menstrual Bleeding with Implanon

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prolonged Menstrual Bleeding Concerns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.